Literature DB >> 12826089

Quality of life and the anxiety disorders.

Lena C Quilty1, Michael Van Ameringen, Catherine Mancini, Jonathan Oakman, Peter Farvolden.   

Abstract

Quality of life (QoL) is a concept that has become increasingly used in mental health care. Recent studies have compared the impact of different anxiety disorders on different domains of QoL; however, instruments generally used to assess QoL in this population have varying specificity, considerable redundancy, and occasionally inappropriate content. Three hundred and sixty consecutive admissions to an anxiety disorders clinic were assessed. Participants and clinicians completed a number of QoL measures. Results indicated that impairment measures designed for use with anxiety-disordered samples in fact assess only occupational functioning and relationships and activities outside of occupation, and that individuals with Social Phobia (SP) were more impaired on the latter than those with Panic Disorder (PD). Furthermore, only Social Phobia accounted for unique variance in the three Medical Outcome Study Health Survey (MOS) subscales relevant to quality of life. Of the MOS subscales relevant to symptoms, mood regulation, physical functioning, and pain were associated with compromised overall QoL.

Entities:  

Mesh:

Year:  2003        PMID: 12826089     DOI: 10.1016/s0887-6185(02)00225-6

Source DB:  PubMed          Journal:  J Anxiety Disord        ISSN: 0887-6185


  24 in total

1.  Validity and reliability of the Italian version of the Quality of Life, Enjoyment and Satisfaction Questionnaire.

Authors:  A Rossi; P Rucci; M Mauri; G Maina; F Pieraccini; S Pallanti; J Endicott
Journal:  Qual Life Res       Date:  2005-12       Impact factor: 4.147

2.  Symptom subtype and quality of life in obsessive-compulsive disorder.

Authors:  Carly M Schwartzman; Christina L Boisseau; Nicholas J Sibrava; Maria C Mancebo; Jane L Eisen; Steven A Rasmussen
Journal:  Psychiatry Res       Date:  2017-01-20       Impact factor: 3.222

3.  Quality of life and functional impairment in obsessive-compulsive disorder: a comparison of patients with and without comorbidity, patients in remission, and healthy controls.

Authors:  Jonathan D Huppert; H Blair Simpson; Kore J Nissenson; Michael R Liebowitz; Edna B Foa
Journal:  Depress Anxiety       Date:  2009       Impact factor: 6.505

Review 4.  Components of Cognitive Behavioral Therapy Related to Outcome in Childhood Anxiety Disorders.

Authors:  Chelsea M Ale; Denis M McCarthy; Lilianne M Rothschild; Stephen P H Whiteside
Journal:  Clin Child Fam Psychol Rev       Date:  2015-09

5.  Associations of self-reported anxiety symptoms with health-related quality of life and health behaviors.

Authors:  Tara W Strine; Daniel P Chapman; Rosemarie Kobau; Lina Balluz
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-06       Impact factor: 4.328

6.  A Randomized Controlled Trial of Group Cognitive Behavioral Treatment for Veterans Diagnosed With Chronic Posttraumatic Stress Disorder.

Authors:  Denise M Sloan; William Unger; Daniel J Lee; J Gayle Beck
Journal:  J Trauma Stress       Date:  2018-11-29

7.  Quality of life impairments among adults with social phobia: the impact of subtype.

Authors:  Nina Wong; Dustin E Sarver; Deborah C Beidel
Journal:  J Anxiety Disord       Date:  2011-09-10

8.  An Online- and Mobile-Based Application to Facilitate Exposure for Childhood Anxiety Disorders.

Authors:  Stephen P H Whiteside; Bridget K Biggs; Michael S Tiede; Julie E Dammann; Julie C Hathaway; Marc E Blasi; Deanna Hofschulte; Kristin Vickers
Journal:  Cogn Behav Pract       Date:  2019-02-02

Review 9.  Disability and quality of life in post-traumatic stress disorder: impact of drug treatment.

Authors:  Soraya Seedat; Christine Lochner; Bavanisha Vythilingum; Dan J Stein
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

10.  Social anxiety disorder above and below the diagnostic threshold: prevalence, comorbidity and impairment in the general population.

Authors:  Lydia Fehm; Katja Beesdo; Frank Jacobi; Agnes Fiedler
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-12-14       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.